NEA Management Company’s OnKure Therapeutics OKUR Stock Holding History

NEA Management Company’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.98M	Hold	478,548	–	–	0.11%	24
2025 Q4	$1.39M	Hold	478,548	–	–	0.07%	26
2025 Q3	$1.32M	Hold	478,548	–	–	0.07%	28
2025 Q2	$1.14M	Hold	478,548	–	–	0.09%	29
2025 Q1	$2.06M	Hold	478,548	–	–	0.16%	32
2024 Q4	$4.12M	Sell	478,548 -1	-0%	-$15	0.23%	33
2024 Q3	$8.14M	Hold	478,549	–	–	0.44%	30
2024 Q2	$7.23M	Hold	478,549	–	–	0.54%	29
2024 Q1	$7.94M	Hold	478,549	–	–	0.49%	31
2023 Q4	$7.66M	Hold	478,549	–	–	0.51%	31
2023 Q3	$36.4M	Hold	478,549	–	–	2.81%	11
2023 Q2	$28.3M	Hold	478,549	–	–	2.16%	15
2023 Q1	$28.6M	Hold	478,549	–	–	1.98%	16
2022 Q4	$11.2M	Sell	478,549 -143	-0%	-$3.79K	0.63%	28
2022 Q3	$16M	Hold	478,692	–	–	0.8%	31
2022 Q2	$12.7M	Hold	478,692	–	–	0.65%	32
2022 Q1	$14.1M	Hold	478,692	–	–	0.41%	33
2021 Q4	$40.9M	Hold	478,692	–	–	0.83%	20
2021 Q3	$35.7M	Hold	478,692	–	–	0.42%	22
2021 Q2	$44.7M	Buy	+478,692	New	+$53.4M	0.58%	25

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NEA Management Company's OKUR Position: Q1 2026 in Review

NEA Management Company held its OnKure Therapeutics (OKUR) position steady in Q1 2026 at 478,548 shares worth $1.98M. The position accounts for 0.11% of the portfolio, ranked #24.

NEA Management Company first reported a position in OKUR in Q2 2021 and has held it in 20 quarters since. The position peaked at $44.7M in Q2 2021. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

NEA Management Company held 478,548 shares of OnKure Therapeutics worth $1.98M as of Q1 2026.
NEA Management Company left its OnKure Therapeutics share count unchanged in Q1 2026.
OnKure Therapeutics made up 0.11% of NEA Management Company's portfolio in Q1 2026, its #24 holding.
NEA Management Company first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 20 quarters since.
NEA Management Company's OnKure Therapeutics position peaked at $44.7M in Q2 2021.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.